Table 4. Incidence of exposure-related histopathologic lesions in male rats in the control and treatment groups.
Tissue and lesion | Control | DEHP |
||
100 mg kg–1 per day | 200 mg kg–1 per day | 400 mg kg–1 per day | ||
Testes | ||||
Combined tubules | 0/6 | 1/6 | 1/6 | 5/6a |
Atrophic tubules | 0/6 | 2/6 | 3/6 | 5/6a |
Pycnotic nucleus | 0/6 | 1/6 | 5/6a | 6/6a |
Congestion | 0/6 | 6/6a | 6/6a | 6/6a |
Vacuolization of Sertoli cell | 0/6 | 3/6 | 6/6a | 6/6a |
Cells in the lumen | 0/6 | 2/6 | 5/6a | 6/6a |
Tubules without sperm | 0/6 | 3/6 | 6/6a | 5/6a |
Degeneration of tubules | 0/6 | 6/6a | 6/6a | 6/6a |
Epididymis | ||||
Atrophic tubules | 0/6 | 2/6 | 1/6 | 2/6 |
Spermatogenic cell | 0/6 | 0/6 | 0/6 | 1/6 |
Tight lumens of tubules | 0/6 | 6/6a | 6/6a | 5/6a |
Tubules without sperm | 0/6 | 2/6 | 6/6a | 6/6a |
Less sperm in the lumen | 0/6 | 6/6a | 6/6a | 6/6a |
Prostate gland | ||||
Mononuclear cell infiltration | 0/6 | 3/6 | 2/6 | 6/6a |
Atrophic tubules | 0/6 | 6/6a | 6/6a | 6/6a |
Prostatic intraepithelial neoplasia | 0/6 | 5/6a | 6/6a | 6/6a |
Seminal vesicle | ||||
Decrement of secretion | 0/6 | 6/6a | 6/6a | 6/6a |
Cells in the lumen | 0/6 | 5/6a | 5/6a | 3/6 |